Biodegradable Long-Acting Injectables: Platform Technology and Industrial Challenges
Handbook of Experimental Pharmacology · 2023
DOI: 10.1007/164_2023_651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Handbook of Experimental Pharmacology, 2023. Verfasst von Marieta Duvnjak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Technical Research and Development, Novartis Pharma AG, Basel, Switzerland. Hauptthemen laut MEDLINE: Lactic Acid, Polyglycolic Acid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Technical Research and Development, Novartis Pharma AG, Basel, Switzerland.
- Technical Research and Development, Novartis Pharma AG, Basel, Switzerland. farshad.ramazani@novartis.com.
Zitieren
APA
Duvnjak, M., Villois, A., & Ramazani, F. (2023). Biodegradable Long-Acting Injectables: Platform Technology and Industrial Challenges. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2023_651
Vancouver
Duvnjak M, Villois A, Ramazani F. Biodegradable Long-Acting Injectables: Platform Technology and Industrial Challenges. Handbook of Experimental Pharmacology. 2023. doi:10.1007/164_2023_651
BibTeX
@article{Duvnjak2023,
author = {Duvnjak, Marieta and Villois, Alessia and Ramazani, Farshad},
title = {Biodegradable Long-Acting Injectables: Platform Technology and Industrial Challenges},
journal = {Handbook of Experimental Pharmacology},
year = {2023},
doi = {10.1007/164_2023_651}
}
EUVIMED